H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), extended his heartfelt congratulations, on behalf of all the SFDA employees, to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and to the Crown Prince and Prime Minister, H.R.H. Prince Mohammed bin Salman bin Abdulaziz on the Saudi national football team’s qualification for the 2026 FIFA World Cup.

H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), met at the Authority’s headquarters in Riyadh with several chief executives and representatives of local and international pharmaceutical companies to discuss key issues and opportunities that will contribute to the growth and support of the pharmaceutical sector in the Kingdom.

H.E. the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham S. Aljadhey, received today H.E. the Syrian Minister of Health,  Dr. Musaab Nazzal al-Ali, and his accompanying delegation at the SFDA headquarters in Riyadh.

His Excellency Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), participated in the annual national blood donation campaign initiated by His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister. Dr. Aljadhey and a number of SFDA leaders and employees joined the campaign, which was held at the Authority’s headquarters in Riyadh.

The Hack4SaferPlates Hackathon concluded today, marking a major milestone in promoting food safety innovation across the Near East and North Africa (NENA) region. Hosted by the Saudi Food and Drug Authority (SFDA), the event was organized by the Food and Agriculture Organization of the United Nations (FAO) as an initiative from the FAO Regional Food Safety Research and Innovation Network, with the goal of fostering innovative and sustainable food safety solutions. The two-day hackathon, held at the SFDA headquarters in Riyadh, was attended by H.E. Dr. Hisham S. Aljadhey, the SFDA CEO.

In the presence of H.E.  Dr. Hisham S. Aljadhey, CEO of the SFDA, the Saudi Food and Drug Authority (SFDA) concluded the “Waedoon” Program, which was launched in October 2024. The program offered specialized training courses to build leadership skills with the participation of 26 professionals of specialists and department heads across the SFDA's sectors. 

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Prof. Dr. Hisham S. Aljadhey, led the Authority's delegation participating in the 41st Annual Meeting of the International Society of Pharmacoepidemiology (ISPE), which took place in Washington, D.C., from August 22 to 26. The meeting was attended by a number of heads and representatives of counterpart drug regulatory authorities from around the world.

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Prof. Dr. Hisham S. Aljadhey, chaired a roundtable meeting at the U.S. Chamber of Commerce in Washington, D.C. The meeting, which included Mr.Steve Lutes, the Chamber's Vice President for the Middle East, representatives from major U.S. companies, and the Saudi Commercial Attaché, focused on exploring opportunities for cooperation and investment within the SFDA’s areas of expertise.

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Prof. Dr. Hisham S. Aljadhey, recently met with the Cultural Attaché at the Saudi Embassy in Washington, Dr. Tahani Al-Baiz, along with a group of Saudi scholarship students. The meeting, which took place at the Cultural Mission headquarters, was held on the sidelines of the SFDA’s participation in the 41st Annual Meeting of the International Society for Pharmacoepidemiology (ISPE).

The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Prof. Dr. Hisham S. Aljadhey, recently held a series of meetings with academic institutions in the United States. The engagements, held on the sidelines of his participation at the 41st Annual Meeting of the International Society for Pharmacoepidemiology (ISPE), came as part of  the SFDA's commitment to enhancing cooperation and exchanging expertise, which contributes to strengthening its scientific and regulatory standing.